FFA
BCYC

Farther Finance Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Farther Finance Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-218
Closed -$1.54K – 5766
2025
Q4 		$1.54K Buy
+218
New +$1.61K ﹤0.01% 4787

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Farther Finance Advisors's BCYC Position: Q1 2026 in Review

Farther Finance Advisors sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 218 shares — an estimated $1.54K sold.

Farther Finance Advisors first reported a position in BCYC in Q4 2025 and held it in 1 quarter. The position peaked at $1.54K in Q4 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Farther Finance Advisors reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 218 Bicycle Therapeutics shares in Q1 2026, an estimated $1.54K.
  • Farther Finance Advisors first reported a position in Bicycle Therapeutics in Q4 2025 and held it in 1 quarter.
  • Farther Finance Advisors's Bicycle Therapeutics position peaked at $1.54K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.